Absorption |
Blood-Brain Barrier | BBB+ | 0.6663 |
Human Intestinal Absorption | HIA+ | 0.9946 |
Caco-2 Permeability | Caco2+ | 0.8416 |
P-glycoprotein Substrate | Substrate | 0.6618 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8918 |
Non-inhibitor | 0.9235 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8387 |
Distribution |
Subcellular localization | Mitochondria | 0.8347 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8220 |
CYP450 2D6 Substrate | Substrate | 0.8886 |
CYP450 3A4 Substrate | Non-substrate | 0.6800 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7551 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8989 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.5536 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8491 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7728 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8234 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9386 |
Non-inhibitor | 0.6063 |
AMES Toxicity | Non AMES toxic | 0.9139 |
Carcinogens | Non-carcinogens | 0.9261 |
Fish Toxicity | High FHMT | 0.8589 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8981 |
Honey Bee Toxicity | High HBT | 0.5246 |
Biodegradation | Not ready biodegradable | 0.9905 |
Acute Oral Toxicity | II | 0.6456 |
Carcinogenicity (Three-class) | Non-required | 0.6018 |